AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2013
Jun 25, 2013
31046_dirs_2013-06-25_2420d961-e10d-42a4-9035-a39c32584b99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-06-19
Reporting Person: HBM Healthcare Investments (Cayman) Ltd. (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series Four Senior Preferred Stock | $0 | Common Stock (280178) | Direct | ||
| Series Five Junior Preferred Stock | $0 | Common Stock (1561317) | Direct |
Footnotes
F1: Each share of issuer's Series Four Senior Preferred Stock will be automatically converted into 1 share of issuer's Common Stock immediately upon the closing of the issuer's firm commitment underwritten public offering pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO"), and has no expiration date.
F2: Each share of issuer's Series Five Junior Preferred Stock will be automatically converted into 1 share of issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expieration date.